Other posts you might like:

News, Announcement

Now Hiring: Director, Business Development & Member Engagement

Who we are and what we do Life Sciences Ontario is a member-driven organization that represents and promotes the provinc...
News

Life Sciences Ontario Celebrates Excellence and Innovation in Life Sciences with 2026 Awards Announcement

TORONTO, ON – January 15th, 2026 - Life Sciences Ontario (LSO) proudly announces the recipients of the 2026 LSO Awards, ...
News, Opinion

Life Sciences Ontario (LSO) welcomes Budget 2025: Building Canada Strong and the federal government’s continued investment in innovation, research, and the life sciences sector

Ontario’s life sciences sector contributes $58.1 billion to Ontario’s GDP, generates $8.8 billion in government revenue,...
Press Release

Catalyzing Ontario’s Life Sciences Economy: Read Life Sciences Ontario’s New Report

TORONTO, ON – [25 June 2025]: Life Sciences Ontario (LSO), in partnership with Shift Health, has just released a new rep...
July 18, 2022
Uncategorized

LSO’S RESPONSE TO PMPRB INTERIM GUIDELINES CONSULATION

All stakeholders have a role in ensuring Canada can attract research and new medicine launches as we rebuild from the pandemic. In this context, LSO has provided a number of general recommendations and considerations to help guide the PMPRB’s approach for its interim guidelines period and beyond. Read LSO’s submission to learn more LSO_PMPRB interm guidelines submission_Final

Author: penny@lifesciencesontario.ca